Molecular mechanisms of hepatocellular carcinoma
RN Aravalli, CJ Steer, ENK Cressman - Hepatology, 2008 - journals.lww.com
Hepatocellular carcinoma (HCC) typically has poor prognosis, because it is often diagnosed
at an advanced stage. Heterogeneous phenotypic and genetic traits of affected individuals …
at an advanced stage. Heterogeneous phenotypic and genetic traits of affected individuals …
The diverse roles and dynamic rearrangement of vimentin during viral infection
Y Zhang, Z Wen, X Shi, YJ Liu… - Journal of cell …, 2021 - journals.biologists.com
Epidemics caused by viral infections pose a significant global threat. Cytoskeletal vimentin is
a major intermediate filament (IF) protein, and is involved in numerous functions, including …
a major intermediate filament (IF) protein, and is involved in numerous functions, including …
miR-221 overexpression contributes to liver tumorigenesis
MicroRNA (miRNAs) are negative regulators of gene expression and can function as tumor
suppressors or oncogenes. Expression patterns of miRNAs and their role in the …
suppressors or oncogenes. Expression patterns of miRNAs and their role in the …
Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter
BACKGROUND & AIMS: In addition to genetic alterations, epigenetic changes underlie
tumor progression and metastasis. Promoter methylation can silence tumor suppressor …
tumor progression and metastasis. Promoter methylation can silence tumor suppressor …
[HTML][HTML] Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic …
AIM: Expression of heat shock proteins (HSPs) is frequently up-regulated in hepatocellular
carcinoma (HCC), which evolves from dysplastic nodule (DN) and early HCC to advanced …
carcinoma (HCC), which evolves from dysplastic nodule (DN) and early HCC to advanced …
Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues
W Sun, B Xing, Y Sun, X Du, M Lu, C Hao, Z Lu… - Molecular & cellular …, 2007 - ASBMB
Hepatocellular carcinoma (HCC) is a highly malignant tumor, and chronic infection with
hepatitis B virus is one of its major risk factors. To identify the proteins involved in HCC …
hepatitis B virus is one of its major risk factors. To identify the proteins involved in HCC …
Overexpression of alpha enolase in hepatitis C virus‐related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis
M Takashima, Y Kuramitsu, Y Yokoyama, N Iizuka… - …, 2005 - Wiley Online Library
To identify proteins that could be molecular targets for diagnosis and treatment of hepatitis C
virus‐related hepatocellular carcinoma (HCV‐related HCC), we used a proteomic approach …
virus‐related hepatocellular carcinoma (HCV‐related HCC), we used a proteomic approach …
[HTML][HTML] Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer
FR Jazii, Z Najafi, R Malekzadeh… - World journal of …, 2006 - ncbi.nlm.nih.gov
AIM: To assess the proteome of normal versus tumor tissue in squamous cell carcinoma of
the esophagus (SCCE) in Iranian patients and compare our results with former reports by …
the esophagus (SCCE) in Iranian patients and compare our results with former reports by …
Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity …
Laser capture microdissection (LCM) is a powerful tool that enables the isolation of specific
cell types from tissue sections, overcoming the problem of tissue heterogeneity and …
cell types from tissue sections, overcoming the problem of tissue heterogeneity and …
[HTML][HTML] Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
C An, YA Choi, D Choi, YH Paik, SH Ahn… - Clinical and …, 2015 - ncbi.nlm.nih.gov
Methods Patients with early-stage HCC (n= 175) who underwent two or more serial dynamic
imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were …
imaging studies without any anticancer treatment at two tertiary care hospitals in Korea were …